 Modern's COVID-19 vaccine could become the second shot given to adolescents in the European Union after regulators on Friday recommended approving it for 12 to 17-year-olds. The use of the vaccine will be the same in adolescents as in people over 18, the European Medicines Agency EMA said, adding that the shot produced a comparable antibody response to that seen in 18 to 25-year-olds. Modern's vaccinating children has been considered important for reaching herd immunity and in light of the highly contagious Delta variant. Moderna is in May and said that the vaccine was found to be safe and effective in teenagers. So you get notified about fresh news updates.